Patients with rheumatoid arthritis may be more likely to develop atherosclerosis if they have high levels of inflammation and cardiovascular risk factors. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Patients with rheumatoid arthritis often have a higher risk of developing cardiovascular diseases such as coronary […]
Month: June 2015
Low-dose methotrexate may be the best starting option for patients initiating treatment with adalimumab
Some medicines used to treat inflammatory diseases such as rheumatoid arthritis may have different efficacy and safety depending on the dose used. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Methotrexate is commonly used in patients with rheumatoid arthritis, both on its own and in combination […]
Rituximab may reverse fibrosis in patients with systemic sclerosis
Rituximab may offer a new treatment option in patients with systemic sclerosis. INTRODUCTION Systemic sclerosis is a serious disease of the connective tissues, where the tissue grows abnormally and triggers the immune system to attack itself (autoimmunity). This can cause hardening (fibrosis) and swelling of the skin, as well as joint pain, digestive problems and […]
